José Manuel
Montes Rodríguez
Profesor/a Asociado/a en CC. de la Salud
Hospital Vall d'Hebron
Barcelona, EspañaPublikationen in Zusammenarbeit mit Forschern von Hospital Vall d'Hebron (10)
2020
-
Evaluation of the MD Anderson tumor score for diffuse large B-cell lymphoma in the rituximab era
European Journal of Haematology, Vol. 104, Núm. 5, pp. 400-408
-
New prognosis score including absolute lymphocyte/monocyte ratio, red blood cell distribution width and beta-2 microglobulin in patients with diffuse large B-cell lymphoma treated with R-CHOP: Spanish Lymphoma Group Experience (GELTAMO)
British Journal of Haematology, Vol. 188, Núm. 6, pp. 888-897
2017
-
Validation of the NCCN-IPI for diffuse large B-cell lymphoma (DLBCL): the addition of β2-microglobulin yields a more accurate GELTAMO-IPI
British Journal of Haematology, Vol. 176, Núm. 6, pp. 918-928
2013
-
Adrenalectomy for solid tumor metastases: Results of a multicenter European study
Surgery (United States), Vol. 154, Núm. 6, pp. 1215-1223
2012
-
Impact of apathy on health-related quality of life in recently diagnosed Parkinson's disease: The ANIMO study
Movement Disorders, Vol. 27, Núm. 2, pp. 211-218
2010
-
Amolecular risk score based on 4 functional pathways for advanced classical Hodgkin lymphoma
Blood, Vol. 116, Núm. 8
2008
-
GEMOX-R regimen is a highly effective salvage regimen in patients with refractory/relapsing diffuse large-cell lymphoma: A phase II study
European Journal of Haematology, Vol. 80, Núm. 2, pp. 127-132
2007
-
Tho adjusted International Prognostic Index and β-2-microglobulin predict the outcome after autologous stem cell transplantation in relapsing/refractory peripheral T-cell lymphoma
Haematologica, Vol. 92, Núm. 8, pp. 1067-1074
2004
-
Autologous stem-cell transplantation in diffuse large B-cell non-Hodgkin's lymphoma not achieving complete response after induction chemotherapy: The GEL/TAMO experience
Annals of Oncology, Vol. 15, Núm. 10, pp. 1504-1509
2003
-
High-dose chemotherapy and autologous stem cell transplantation in peripheral T-cell lymphoma: The GEL-TAMO experience
Annals of Oncology, Vol. 14, Núm. 12, pp. 1768-1775